Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy

NCT03340675 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy Cardiomyopathy
Cardiomyopathy, Dilated

Interventions

DRUG: Ifetroban
DRUG: Placebo

Sponsor

Cumberland Pharmaceuticals

Collaborators

[object Object]